[Generic Equivalent Of Actos]
Prescription Required
Quantity:100
Price:$47.99$0.42 per unit
Country:Canada
Please Select... 100 from Canada $47.99 100 from India $55.99 100 from United Kingdom $59.99
The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser.For the best experience on our site, be sure to turn on Javascript in your browser.
Actos-1-MG-Oral-Suspension
Actos is used to help prevent heart attacks and strokes. It is also used for the prevention of cardiovascular diseases, such as hypertension. This medication belongs to a class of drugs called thiazides. It works by increasing blood flow to the heart and its vessels, leading to a better overall health. It is used along with a proper diet and exercise to help lower blood pressure. Lowering your blood pressure helps to relieve the symptoms of heart attacks and strokes.
Nausea, lightheadedness, dizziness, or headaches while taking Actos can occur during or after a meal. If these effects persist or worsen, notify your doctor or pharmacist promptly. Remember that your doctor has prescribed this medication because he or she has judged that the benefit to you is greater than the risk of side effects. Many people using this medication do not have serious side effects. However, remember that everyone's body makes mistakes and has a right to be aware of them. If a side effect is noticed, it is important to notify a doctor or pharmacist immediately. Self-medicating with this drug can lead to serious side effects, including weight gain, diabetes, and certain forms of seizures. Tell your doctor right away if you experience any of these: *Feeling dizzy *Feeling tired *Tired of the dizziness *Feeling jittery *Tired of the jittery *Tired of the jittery *Feeling light-headed *Tailor heartbeat changes *Chest pain *Diarrhea *Swelling in your hands or feet *Trouble sleeping *Unusual hair growth *Nausea *Dizziness *Vomiting *Fainting *Chest/vomit *Stomach pain *Fainting Directions *Bottles of water (for vomiting) *Bpressure skin tests *Blood pressure medications *Blood thinners - this drug may reduce the effectiveness of some blood thinners because of possible decrease in thrombotic risk - this medication may not be used as recommended by your doctor or as directed by your doctor. If you miss a dose, simply skip the missed dose and continue with your regular schedule. Do not take a double dose to make up for a missed one. Consult your doctor if you are using insulin to treat type 2 diabetes. This medication may interact with certain prescription medicines, such as aspirin, warfarin, and blood thinners. Tell your doctor immediately if you have any serious mental or emotional problems. This drug may rarely cause a severe or fatal allergic reaction. See also Precautions section. Normal growths and changes in appetite are observed at doses over 1,000 mg per kg of body weight. Vision changes including increased sensitivity to light, increased heart rate, or sudden vision or hearing decrease the risk of NAION. NAION is a rare condition that usually occurs 10 to 30 minutes after taking Actos. Symptoms may include: *Headache *Dizziness *Drowsiness *Lightheadedness *Tired of the dizzy *Jittery heartbeat changes *Stomach pain *Weakness *Confusion *Sleeping problems *Sleeping too much of this drug can lead to death. A rare condition is a person who has a condition which causes confusion or weakness. This condition is more likely with high blood pressure, diabetes, obesity, or heart disease. Symptoms of confusion or weakness include: * *Feeling faint *Severity of sound *Trouble sleeping *Unusual dizziness *Dry mouth *Difficulty breathing *Dizziness *Fainting *Feelings of unreality *Nervousness *Weakness *Tremor *Numbness *Irritability *Tremors Vision changes *Pain in the arms, hands, or legs *A blocked nose *Irregular heartbeat *Chest pain *Dizziness *Swelling in your hands or feet *Fainting *Loss of consciousness *Trouble speaking *Sweating or sweating *Nausea *Vomiting *Dry mouth *Itching or tingling *Fever *Itching or>] * These ingredients may interfere with the development of a new batch of skin-related reactions (including, but not limited to, photosensitivity). Talk to your doctor, pharmacist, or pharmacist if you have questions about changing your treatment schedule. Your doctor may recommend other measures to alleviate your symptoms.
In April 2017, the U. S. Food and Drug Administration (FDA) approved a drug to treat type 2 diabetes. The generic drug, Actos (pioglitazone), is available for purchase by prescription only.
Actos is a popular diabetes medication that helps control blood sugar levels in people with diabetes. It is the most prescribed diabetes drug in the world, and is a generic version of the popular diabetes drug metformin. Actos has been available since its approval in 1999 and has been used since its launch in 2007. In addition to its use in managing type 2 diabetes, Actos is also approved for the treatment of type 1 diabetes in adults, as well as for managing the symptoms of type 2 diabetes. It is also prescribed for the treatment of type 1 diabetes in children, as well as to help with symptoms of overweight or obesity. Actos has been available in many countries for many years and is often prescribed for people with type 2 diabetes and adults with the condition.
For more information on Actos and diabetes, please read our page or contact our office.
Actos is the brand name for pioglitazone, an oral medication that is used to treat type 2 diabetes. The drug is available as a generic, as a brand name, and as a generic drug under the brand name Actos. Other brand names for pioglitazone include: Actos®, Actos XR® (pioglitazone extended release), Actos XR®, and Actos®.
Actos comes as a tablet or oral suspension that is taken by mouth. It is also available in capsule form that can be taken with or without food.
The FDA approved Actos in 1999. In 2006, the FDA approved the use of Actos to help manage type 2 diabetes. The generic drug Actos is a brand name for the drug pioglitazone, which is available as a generic drug under the brand name Actos.
Actos is used to treat type 2 diabetes and to treat type 1 diabetes. It is used in adults with the condition and in children and adolescents with type 2 diabetes. Actos is also used to treat symptoms of a type 1 diabetes in adults, such as:
Actos can cause a number of side effects. Most of these side effects are mild and disappear once the medicine is discontinued. Less serious but still possible side effects include:
If you experience any of these side effects, stop taking the drug and see your doctor right away. They may adjust your dose or recommend additional tests to check your condition.
Before you start taking Actos, it is important to understand that it is not a drug for the treatment of type 2 diabetes or for the prevention of type 1 diabetes. It is a diabetes drug, and it works in the same way to treat diabetes, but it does not stop the body from producing insulin. Actos is not a weight loss drug, and it does not treat obesity or treat diabetes. It is not meant for immediate use in people with diabetes.
The most serious of the most serious of these side effects are:
In some cases, the side effects can be serious. If you experience any of these symptoms, stop taking Actos and see your doctor right away.
If you experience any of these side effects, contact your doctor immediately. They may change your treatment plan or may recommend additional tests to check your condition.
Actos, also known as pioglitazone, is an oral anti-psychotic medication used primarily in the treatment of dyslipidemia caused by plasma cell disorders in patients with various metabolic disorders. Actos has been a significant in diabetic patients due to its ability to increase the plasma levels of very lipids, thereby reducing total and plasma triglycerides, and it has been a well-established safety and efficacy standard in clinical practice. The primary objective of Actos is to decrease the risk of developing this type of diabetic nephropathy in individuals with insulin-dependent diabetes mellitus (DM) or mixed insulin-dependent diabetes mellitus type 2 (DM-MIMS2) or insulin resistance (IR) who are at a greater risk for developing the condition.
The global market for Actos, which is segmented into metformin-type type 2 diabetes and metformin-type type 1 diabetes, is projected to reach USD 3.34 billion by 2032, growing at a Compound Annual Growth Rate (CAGR) of 5.15% from 2024 to 2032[3].
The market for Actos is influenced by several factors, including the North America and Europe, the Asia-Pacific region, and the Middle East and Africa. North America holds a significant share of the global Actos market with a market size of USD 1.77 billion in 2024 and a market share of around 30% in 2015[2].
The Asia-Pacific region, on the other hand, is experiencing a high growth rate due to its expanding economy, increasing awareness about infectious diseases, and increasing awareness of the importance of managing chronic diseases[2][3].
The global Actos market is anticipated to experience steady growth driven by the increasing prevalence of diabetic complications, rising healthcare expenditure, and growing awareness about health issues related to diabetes mellitus[1].
The increasing prevalence of diabetic complications due to the rise in diabetic ketoacidosis (DKA) and hyper-triglyceridemia (“trritional deficiencies”) is a major driver of the Actos market growth. Lower socioeconomic problems, high blood pressure, obesity, and an increased consumption of fatty foods, leading to an over-prescription of medications like Actos, are also major trends in the Actos market[1][3].
The Actos market is segmented based on several criteria:
The market is segmented based on several drivers:
The Actos market is significantly impacted by rising diabetes prevalence and increasing awareness about these issues. As of 2023, the global Actos market size was valued at USD 1.77 billion and is expected to grow at a CAGR of 5.15% from 2024 to 2032[3].
The increasing prevalence of diabetes in the aging population and the growing geriatric population are driving the Actos market growth. The aging population is also a significant driver, contributing to significant market weaknesses. The rising incidence of cardiovascular diseases, diabetes-related complications, and kidney failure is also driving the demand for Actos[1].
Despite the growth prospects, the Actos market faces challenges such as: